Literature DB >> 5471921

Experimental allergic encephalomyelitis: a light and electron microscope study of remyelination and "sclerosis" in vitro.

C S Raine, M B Bornstein.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 5471921

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


× No keyword cloud information.
  8 in total

1.  Production of lymphoid tissue in the rat brain by implants containing phytohemagglutinin.

Authors:  L J Stensaas; W W Horsley
Journal:  Acta Neuropathol       Date:  1975       Impact factor: 17.088

2.  Attenuation of astroglial reactivity by interleukin-10.

Authors:  V Balasingam; V W Yong
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

3.  Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo.

Authors:  V W Yong; R Moumdjian; F P Yong; T C Ruijs; M S Freedman; N Cashman; J P Antel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  In vivo demyelination by antimyelin antibodies.

Authors:  R M Williams; S Krakowka; A Koestner
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

5.  In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin.

Authors:  H Lassmann; K Kitz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

6.  In vivo CNS demyelination mediated by anti-galactocerebroside antibody.

Authors:  K Ozawa; T Saida; K Saida; H Nishitani; M Kameyama
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 7.  Multiple sclerosis. Current etiological concepts.

Authors:  F J Seil
Journal:  Calif Med       Date:  1972-05

8.  An immunohistochemical study of myelin proteins during remyelination in the central nervous system.

Authors:  S K Ludwin; N H Sternberger
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.